Barely Significant
← all excerpts

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.

BMC Cancer · 2008 · PMC2435120 · PMID 18513385

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
In contrast, methylated breast cancer specimens exhibited a highly significant (P < 0.001) loss of ID4 expression (median fold change = 12.3).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.